OLYMY (Olympus) Common Stock : $810 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Olympus Common Stock?

Olympus's quarterly common stock increased from Jun. 2024 ($790 Mil) to Sep. 2024 ($872 Mil) but then declined from Sep. 2024 ($872 Mil) to Dec. 2024 ($810 Mil).

Olympus's annual common stock declined from Mar. 2022 ($1,051 Mil) to Mar. 2023 ($933 Mil) and declined from Mar. 2023 ($933 Mil) to Mar. 2024 ($832 Mil).

Olympus Common Stock Historical Data

The historical data trend for Olympus's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Common Stock Chart

Olympus Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Common Stock

Get a 7-Day Free Trial

1,157.67

1,146.68

1,051.15

932.51

831.96

Olympus Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															865.69	831.96	789.58	871.91	810.35

Olympus Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Olympus Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (OTCPK:OLYMY) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

OCPNF:USA 7733:Japan OLY1:Germany

Address

Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914

Website

http://www.olympus.co.jp

Olympus is a medical device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2024, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.